ストックスクリーナーアプリを入手
2.65
0.76%
0.02
前日終値:
$2.63
開ける：
$2.62
24時間の取引高:
673.63K
Relative Volume:
0.42
時価総額：
$897.49M
収益：
$787.89M
当期純損益:
$20.56M
株価収益率:
45.30
EPS:
0.0585
ネットキャッシュフロー:
$96.54M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-1.49%
6か月 パフォーマンス:
-6.03%
1年 パフォーマンス:
-40.85%
1日の値動き範囲:
$2.5901
$2.66
1週間の範囲:
$2.48
$2.775
52週間の値動き範囲:
$1.77
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
名前
Goodrx Holdings Inc
セクター
電話
(855) 268-2822
住所
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX vs VEEV, BTSG, TEM, HQY, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.65 | 897.49M | 787.89M | 20.56M | 96.54M | 0.0585 |
VEEV
Veeva Systems Inc
|
159.54 | 25.92B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
63.23 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
47.82 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.34 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
65.34 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2026-01-22 | ダウングレード | Jefferies | Buy → Hold |
| 2025-12-09 | 開始されました | Barclays | Underweight |
| 2025-08-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-08-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-02 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-08-10 | アップグレード | DA Davidson | Neutral → Buy |
| 2023-07-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 開始されました | Citigroup | Buy |
| 2022-11-04 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-12 | 開始されました | DA Davidson | Neutral |
| 2022-06-10 | ダウングレード | Goldman | Buy → Neutral |
| 2022-06-06 | 再開されました | BofA Securities | Buy |
| 2022-06-01 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-05-10 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 開始されました | Wells Fargo | Equal Weight |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2022-03-15 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 繰り返されました | Barclays | Overweight |
| 2022-03-01 | 繰り返されました | BofA Securities | Neutral |
| 2022-03-01 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-03-01 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 繰り返されました | Evercore ISI | Outperform |
| 2022-03-01 | 繰り返されました | Goldman | Buy |
| 2022-03-01 | 繰り返されました | JP Morgan | Underweight |
| 2022-03-01 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-03-01 | 繰り返されました | SVB Leerink | Outperform |
| 2022-01-07 | 開始されました | Goldman | Buy |
| 2021-12-21 | 開始されました | Stephens | Overweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-08-31 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-08-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-04-06 | 再開されました | Evercore ISI | Outperform |
| 2021-01-25 | 開始されました | Guggenheim | Buy |
| 2020-11-19 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 開始されました | Barclays | Equal Weight |
| 2020-10-19 | 開始されました | BofA Securities | Neutral |
| 2020-10-19 | 開始されました | Citigroup | Buy |
| 2020-10-19 | 開始されました | Cowen | Outperform |
| 2020-10-19 | 開始されました | Credit Suisse | Outperform |
| 2020-10-19 | 開始されました | Deutsche Bank | Hold |
| 2020-10-19 | 開始されました | Goldman | Neutral |
| 2020-10-19 | 開始されました | JP Morgan | Neutral |
| 2020-10-19 | 開始されました | Morgan Stanley | Overweight |
| 2020-10-19 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 開始されました | SVB Leerink | Outperform |
| 2020-10-19 | 開始されました | UBS | Buy |
すべてを表示
Goodrx Holdings Inc (GDRX) 最新ニュース
GoodRx Holdings, Inc. (GDRX) Q1 earnings match estimates - MSN
GoodRx (GDRX) Q1 earnings: Taking a look at key metrics versus estimates - MSN
Trevor Bezdek (GDRX) receives 110K RSUs vesting in 2027 - Stock Titan
GoodRx Leverages Companion Offering to Bolster Recurring Revenue StreamsQuarterly Earnings Report - newsline.com
GoodRx Holdings Expands Recurring Revenue Streams Through Companion Pet Prescription Platform - newsline.com
GoodRx Holdings Strengthens Recurring Revenue Base with Companion Product ExpansionManagement Tone Analysis - newsline.com
GoodRx Launches Companion to Strengthen Recurring Revenue StreamsMargin Compression Risk - newsline.com
GoodRx Boosts Recurring Revenue with Companion Subscription OfferingEarnings Whisper Number - newsline.com
GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion - Insider Monkey
GoodRx Launches 'Companion' to Bolster Recurring Revenue StreamEBITDA Margin Trends - newsline.com
3 Penny Stocks With Market Caps Over $100M To Watch - simplywall.st
GoodRx (NASDAQ: GDRX) director grant adds 4,642 deferred stock units - Stock Titan
GoodRx (NASDAQ: GDRX) director receives 4,642 deferred stock units - Stock Titan
How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation - Yahoo Finance
GoodRx launches $14.99 monthly healthcare subscription service - Investing.com UK
GoodRx (GDRX) Introduces New Monthly Subscription Service - GuruFocus
GoodRx (GDRX) Launches Subscription Plan for Affordable Healthca - GuruFocus
New $14.99 GoodRx membership bundles free meds and $19 telehealth - Stock Titan
GoodRx Surges 5.28% – Prescription Savings Platform Tests Key Resistance ZoneWedge Breakout - newsline.com
GoodRx Holdings Q3 2025 Earnings Preview - MSN
SA analyst upgrades/downgrades: NVDA, META, GDRX, JPM - Seeking Alpha
Hims & Hers Deepens Personalized Care Through Platform Expansion - TradingView
GoodRx: Evident Stabilization, But GLP-1 Dependence Is A Risk (Upgrade) (NASDAQ:GDRX) - Seeking Alpha
GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade) (NASDAQ:GDRX) - Seeking Alpha
GoodRx Holdings (GDRX) price target increased by 10.24% to 3.17 - MSN
The 5 Most Interesting Analyst Questions From GoodRx’s Q1 Earnings Call - Yahoo Finance
GoodRx (GDRX) CAO exercises RSUs and delivers shares to cover taxes - Stock Titan
GoodRx (NASDAQ: GDRX) executive exercises 44,779 RSUs, 19,726 shares for taxes - Stock Titan
GoodRx Holdings' (NASDAQ:GDRX) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
GDRX Maintained by Citigroup -- Price Target Raised to $4.00 - GuruFocus
GoodRx Holdings Is Maintained at Buy by Citigroup - Moomoo
Jim Cramer on GoodRx: “I’m Going to Grant You That Spec” - Insider Monkey
Some May Be Optimistic About GoodRx Holdings' (NASDAQ:GDRX) Earnings - simplywall.st
GDRX (NASDAQ: GDRX) Form 144 — 43,100-share proposed sale - Stock Titan
Why Jim Cramer Says 'Pull The Trigger' On Chevron - Benzinga
GoodRx (GDRX) awards 54,494 RSUs to Chief Accounting Officer Thomas Chan - Stock Titan
Earnings call transcript: GoodRx Q1 2026 beats revenue forecast, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: GoodRx Q1 2026 beats revenue forecast, stock rises - Investing.com Nigeria
TradingKey - TradingKey
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and DaVita (DVA) - The Globe and Mail
GDRX Maintained by TD Cowen -- Price Target Raised to $4.00 - GuruFocus
Goodrx Holdings Inc (GDRX) 財務データ
収益
当期純利益
現金流量
EPS
0.30%
0.72%
大文字化:
|
ボリューム (24 時間):